Overview of Springhood Ventures
- $20M venture capital fund
- Founded and led by John Parker, building on 9 years of success in child health-focused venture investing
- Investing in great businesses that improve the health of children
- Targeting drugs, devices, diagnostics, and software/digital health
- Successful first close April 2024
- 4 investments to date
Investment Thesis
Springhood is a $20MM Seed Stage venture fund backing life science and healthcare companies transforming the health and care of children, leveraging 9 years of success and a 21% IRR running a child health-focused venture program for a leading pediatric foundation.
Fund Portfolio
- Xploro – pediatric patient engagement
- NeoPredics – Clinical decision support for the neonatal intensive care unit
- TMA Precision Health – Reducing the rare disease diagnostic journey from 7 years to 3 months
- Flag Therapeutics – Pediatric brain cancer (DIPG) therapeutic
Fund Impact Goals
- Ultimate goal is additional quality adjusted life years resulting from pediatric intervention
- Near-term goals are patients touched, FDA approval, and clinical trials